WTB RSS
03-16-2012, 02:37 PM
BOSTON (MarketWatch) -- Cytori Therapeutics shares climbed 13% to $3.19 Friday on news that U.S. regulators have approved the company's Puregraft 850 System for body contouring using a patient's own fat. The product is already approved in the EU.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
http://feedads.g.doubleclick.net/~at/2ElJdK17A_Xqr1HcmcY3DC4wKNs/0/di (http://feedads.g.doubleclick.net/~at/2ElJdK17A_Xqr1HcmcY3DC4wKNs/0/da)
http://feedads.g.doubleclick.net/~at/2ElJdK17A_Xqr1HcmcY3DC4wKNs/1/di (http://feedads.g.doubleclick.net/~at/2ElJdK17A_Xqr1HcmcY3DC4wKNs/1/da)
http://feeds.feedburner.com/~ff/marketwatch/marketpulse?d=yIl2AUoC8zA (http://feeds.marketwatch.com/~ff/marketwatch/marketpulse?a=Bus9IQLFbgQ:f1z93Wx3VYk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/marketwatch/marketpulse?i=Bus9IQLFbgQ:f1z93Wx3VYk:F7zBnMyn0Lo (http://feeds.marketwatch.com/~ff/marketwatch/marketpulse?a=Bus9IQLFbgQ:f1z93Wx3VYk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/marketwatch/marketpulse?i=Bus9IQLFbgQ:f1z93Wx3VYk:V_sGLiPBpWU (http://feeds.marketwatch.com/~ff/marketwatch/marketpulse?a=Bus9IQLFbgQ:f1z93Wx3VYk:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/marketwatch/marketpulse?d=qj6IDK7rITs (http://feeds.marketwatch.com/~ff/marketwatch/marketpulse?a=Bus9IQLFbgQ:f1z93Wx3VYk:qj6IDK7rITs)
http://feeds.feedburner.com/~r/marketwatch/marketpulse/~4/Bus9IQLFbgQ
More... (http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/Bus9IQLFbgQ/story.aspx)
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
http://feedads.g.doubleclick.net/~at/2ElJdK17A_Xqr1HcmcY3DC4wKNs/0/di (http://feedads.g.doubleclick.net/~at/2ElJdK17A_Xqr1HcmcY3DC4wKNs/0/da)
http://feedads.g.doubleclick.net/~at/2ElJdK17A_Xqr1HcmcY3DC4wKNs/1/di (http://feedads.g.doubleclick.net/~at/2ElJdK17A_Xqr1HcmcY3DC4wKNs/1/da)
http://feeds.feedburner.com/~ff/marketwatch/marketpulse?d=yIl2AUoC8zA (http://feeds.marketwatch.com/~ff/marketwatch/marketpulse?a=Bus9IQLFbgQ:f1z93Wx3VYk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/marketwatch/marketpulse?i=Bus9IQLFbgQ:f1z93Wx3VYk:F7zBnMyn0Lo (http://feeds.marketwatch.com/~ff/marketwatch/marketpulse?a=Bus9IQLFbgQ:f1z93Wx3VYk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/marketwatch/marketpulse?i=Bus9IQLFbgQ:f1z93Wx3VYk:V_sGLiPBpWU (http://feeds.marketwatch.com/~ff/marketwatch/marketpulse?a=Bus9IQLFbgQ:f1z93Wx3VYk:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/marketwatch/marketpulse?d=qj6IDK7rITs (http://feeds.marketwatch.com/~ff/marketwatch/marketpulse?a=Bus9IQLFbgQ:f1z93Wx3VYk:qj6IDK7rITs)
http://feeds.feedburner.com/~r/marketwatch/marketpulse/~4/Bus9IQLFbgQ
More... (http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/Bus9IQLFbgQ/story.aspx)